We are live on ! Find out more
TVGN icon

Tevogen Inc. Common Stock

52 hedge funds and large institutions have $4.16M invested in Tevogen Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

67% more capital invested

Capital invested by funds: $2.49M → $4.16M (+$1.67M)

33% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 15

18% more funds holding

Funds holding: 4452 (+8)

0.02% more ownership

Funds ownership: 0.03%0.04% (+0.02%)

Holders
52
Holders Change
+8
Holders Change %
+18.18%
% of All Funds
0.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
20
Reduced
15
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EWA
51
EverSource Wealth Advisors
Alabama
$54 +$66 +1 New
SG Americas Securities
52
SG Americas Securities
New York
-$17K -324 Closed
Millennium Management
53
Millennium Management
New York
-$14.6K -284 Closed

TVGN Hedge Fund Activity: Q1 2025 in Review

52 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q1 2025, worth a combined $4.16M — up 67% from $2.49M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TVGN positions and 2 closed out — a net gain of 8 holders — while 20 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.18M. The largest seller was Goldman Sachs, cutting an estimated $30.8K.

  • 52 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q1 2025, up from 44 in Q4 2024.
  • Funds reported $4.16M of Tevogen Inc. Common Stock stock for Q1 2025, up 67% quarter-over-quarter.
  • 10 funds opened new Tevogen Inc. Common Stock positions in Q1 2025 and 2 closed out, a net change of +8 holders.
  • The largest Tevogen Inc. Common Stock buyer in Q1 2025 was Vanguard Group, an estimated $1.18M added.
  • The largest Tevogen Inc. Common Stock seller in Q1 2025 was Goldman Sachs, an estimated $30.8K sold.

Based on aggregated 13F filings for Q1 2025.